Azacitidine plus lenalidomide for untreated AML patients ineligible for conventional chemotherapy Meeting Abstract


Authors: Pollyea, D. A.; Zehnder, J. L.; Coutre, S.; Gotlib, J.; Gallegos, L.; Greenberg, P.; Zhang, B.; Liedtke, M.; Levine, R. L.; Medeiros, B. C.
Abstract Title: Azacitidine plus lenalidomide for untreated AML patients ineligible for conventional chemotherapy
Meeting Title: 54th Annual Meeting and Exposition of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 120
Issue: 21
Meeting Dates: 2012 Dec 8-11
Meeting Location: Atlanta, GA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2012-11-01
Language: English
ACCESSION: WOS:000313838906082
PROVIDER: wos
DOI: 10.1182/blood.V120.21.3575.3575
Notes: --- - Meeting Abstract: 3575 - 54th Annual Meeting and Exposition of the American-Society-of-Hematology (ASH) - DEC 08-11, 2012 - Atlanta, GA - "Source: Wos"
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Ross Levine
    775 Levine